Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Alcohol Use Disorder and PTSD
NCT02058251Phase 1Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2014
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in alcohol use disorder (AUD) (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Alcohol Craving at 2 hours. Started Feb 2014; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02058251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058251.